Login

LIFECORE BIOMEDICAL INC 4/A SEC Filings

Filed On Filing
09 Apr 2007 Form 4/A: Runnells John E, Director

Sold 40,500 shares ($720K)

26 Jan 2007 Form 4/A: Perkins Richard W, Director

Holds 38,000 shares of Common Stock

26 Jan 2007 Form 4/A: Griffith Luther T, Director

Holds 0 shares of Common Stock

18 Aug 2006 Form 4/A: Beckham Benjamin, VP of ORD Sales & Marketing

Received 7,000 shares as a grant or award · Granted 60,000 Stock Option (Right to Buy)

18 Aug 2006 Form 4/A: Hall James G, VP Technical Operations

Received 3,500 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)

28 Oct 2004 Form 4/A: Noel David M, CFO & VP of Finance

Received 10,000 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)

28 Oct 2004 Form 4/A: Hiebert Larry D, VP Operations

Received 10,000 shares as a grant or award · Granted 30,000 Stock Option (Right to Buy)

28 Oct 2004 Form 4/A: Decarie Andre P, VP ORD Sales & Marketing

Granted 30,000 Stock Option (Right to Buy) · Received 10,000 shares as a grant or award

28 Oct 2004 Form 4/A: Allingham Dennis J, Director

Granted 100,000 Stock Option (Right to Buy) · Received 20,000 shares as a grant or award

14 Jan 2004 Form 4/A: Decarie Andre P, VP Sales and Marketing

Granted 30,000 Stock Option · Granted 2,500 Stock Option · Granted 5,000 Stock Option

14 Jan 2004 Form 4/A: Allingham Dennis J, EXECUTIVE VP AND CFO

Granted 3,500 Stock Option · Granted 5,000 Stock Option

14 Jan 2004 Form 4/A: Bracke James W, Director

Granted 5,000 Stock Option · Granted 6,000 Stock Option

14 Jan 2004 Form 4/A: Olson Colleen M, VP Corporate Administration

Granted 2,500 Stock Option · Granted 3,000 Stock Option

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support